These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3605388)

  • 1. Inhibition of VP and OT release by water in hypovolemia is independent of opioid peptides.
    Rosella-Dampman LM; Hartman RD; Summy-Long JY
    Am J Physiol; 1987 Jul; 253(1 Pt 2):R31-8. PubMed ID: 3605388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of naloxone on the release of neurohypophysial hormones in normotensive and spontaneously hypertensive rats.
    Rosella-Dampman LM; Emmert SE; Keil LC; Summy-Long JY
    Brain Res; 1985 Jan; 325(1-2):205-14. PubMed ID: 3978414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration.
    Summy-Long JY; Rosella-Dampman LM; McLemore GL; Koehler E
    Neuroendocrinology; 1990 Apr; 51(4):376-84. PubMed ID: 1971712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of the magnocellular system in rats to hypovolemia and cholecystokinin during pregnancy and lactation.
    Koehler EM; McLemore GL; Martel JK; Summy-Long JY
    Am J Physiol; 1994 Apr; 266(4 Pt 2):R1327-37. PubMed ID: 8184979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous opioid peptides inhibit oxytocin release in the lactating rat after dehydration and urethane.
    Hartman RD; Rosella-Dampman LM; Summy-Long JY
    Endocrinology; 1987 Aug; 121(2):536-43. PubMed ID: 3595530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of various opioid peptides on vasopressin and oxytocin release from the rat pituitary in vitro.
    Maysinger D; Vermes I; Tilders F; Seizinger BR; Gramsch C; Höllt V; Herz A
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):191-5. PubMed ID: 6152015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Neurohypophyseal Vasopressin Release is Associated with Increased Opioid Inhibition of Oxytocin Release.
    Heijning BJ; Herik IK; Rots NY; Greidanus TB
    J Neuroendocrinol; 1991 Feb; 3(1):57-64. PubMed ID: 19215447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone effects on plasma vasopressin and oxytocin concentrations elevated by histamine, nicotine, isoproterenol and an acute increase in [NaCl] in cerebrospinal fluid.
    Summy-Long JY; Denlinger C; Palm D; Hartman RD; Rosella-Dampman LM
    Neuroendocrinology; 1986; 44(2):157-62. PubMed ID: 3796791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone differentially alters naltrexone effects on vasopressin and oxytocin release during tail electroshock.
    Rosella-Dampman LM; Summy-Long JY
    Brain Res Bull; 1985 Dec; 15(6):587-93. PubMed ID: 4084815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of release of neurohypophysial hormones by endogenous opioid peptides in pregnant and parturient rats.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Brain Res; 1986 Sep; 382(2):352-9. PubMed ID: 3756522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynorphin A inhibits and naloxone increases the electrically stimulated release of oxytocin but not vasopressin from the terminals of the neural lobe.
    Bondy CA; Gainer H; Russell JT
    Endocrinology; 1988 Apr; 122(4):1321-7. PubMed ID: 2894296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin and vasopressin in rat hypophysial portal blood: experimental studies in normal and Brattleboro rats.
    Horn AM; Robinson IC; Fink G
    J Endocrinol; 1985 Feb; 104(2):211-24. PubMed ID: 3968510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central oxytocin mediates inhibition of sodium appetite by naloxone in hypovolemic rats.
    Blackburn RE; Stricker EM; Verbalis JG
    Neuroendocrinology; 1992 Aug; 56(2):255-63. PubMed ID: 1407380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid neurosecretory and cardiovascular response to osmotic stimulation in conscious mice.
    Chen H; Morris M; Key MP; Chen Y
    Neuroendocrinology; 2004; 80(4):225-32. PubMed ID: 15604594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreases in arterial pressure activate oxytocin neurons in conscious rats.
    Schiltz JC; Hoffman GE; Stricker EM; Sved AF
    Am J Physiol; 1997 Oct; 273(4):R1474-83. PubMed ID: 9362314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid changes in poly (A) tail length of vasopressin and oxytocin mRNAs form a common early component of neurohypophyseal peptide gene activation following physiological stimulation.
    Carter DA; Murphy D
    Neuroendocrinology; 1991 Jan; 53(1):1-6. PubMed ID: 1675437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of interleukin-1beta in the magnocellular system to salt-loading.
    Summy-Long JY; Hu S; Pruss A; Chen X; Phillips TM
    J Neuroendocrinol; 2006 Dec; 18(12):926-37. PubMed ID: 17076768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat.
    Ishikawa S; Schrier RW
    J Clin Invest; 1982 Mar; 69(3):666-72. PubMed ID: 6174549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological assessment of the site of action of opioids on the release of vasopressin and oxytocin in the rat.
    Van de Heijning BJ; Koekkoek-Van den Herik I; Maigret C; Van Wimersma Greidanus TB
    Eur J Pharmacol; 1991 May; 197(2-3):175-80. PubMed ID: 1680708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.